Clinical trial
Randomized, Cross Over, Controlled, Multi-centric Study to Assess Whether Type 1 Diabetic Patients in Sub-optimal Glycemic Control Can Improve Using the Continuous Glucose Values of the MiniMed Paradigm REAL-Time Insulin Pump System Versus the MiniMed Paradigm Insulin Pump
NCT00598663 is registered in ClinicalTrials.gov with Medtronic MiniMed, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Cross Over, Controlled, Multi-centric Study to Assess Whether Type 1 Diabetic Patients in Sub-optimal Glycemic Control Can Improve Using the Continuous Glucose Values of the MiniMed Paradigm REAL-Time Insulin Pump System Versus the MiniMed Paradigm Insulin Pump
- Lead sponsor
- Medtronic MiniMed, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2008
- Completion date
- July 31, 2010
- Enrollment
- 153 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.